- Home
- GPRO vs GNFT Comparison
GPRO vs GNFT Comparison
Compare GPRO & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- GNFT
- Stock Information
- Founded
- GPRO 2004
- GNFT 1999
- Country
- GPRO United States
- GNFT France
- Employees
- GPRO N/A
- GNFT N/A
- Industry
- GPRO Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPRO Consumer Discretionary
- GNFT Health Care
- Exchange
- GPRO Nasdaq
- GNFT Nasdaq
- Market Cap
- GPRO 194.6M
- GNFT 216.7M
- IPO Year
- GPRO 2014
- GNFT 2019
- Fundamental
- Price
- GPRO $2.17
- GNFT N/A
- Analyst Decision
- GPRO
- GNFT Strong Buy
- Analyst Count
- GPRO 0
- GNFT 2
- Target Price
- GPRO N/A
- GNFT $10.00
- AVG Volume (30 Days)
- GPRO 10.7M
- GNFT 10.3K
- Earning Date
- GPRO 11-06-2025
- GNFT 09-22-2025
- Dividend Yield
- GPRO N/A
- GNFT N/A
- EPS Growth
- GPRO N/A
- GNFT N/A
- EPS
- GPRO N/A
- GNFT N/A
- Revenue
- GPRO $746,731,000.00
- GNFT $52,994,715.00
- Revenue This Year
- GPRO N/A
- GNFT $3.14
- Revenue Next Year
- GPRO $9.72
- GNFT N/A
- P/E Ratio
- GPRO N/A
- GNFT N/A
- Revenue Growth
- GPRO N/A
- GNFT N/A
- 52 Week Low
- GPRO $0.40
- GNFT $2.55
- 52 Week High
- GPRO $3.05
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- GPRO 52.37
- GNFT 48.03
- Support Level
- GPRO $1.92
- GNFT $3.93
- Resistance Level
- GPRO $2.53
- GNFT $4.45
- Average True Range (ATR)
- GPRO 0.21
- GNFT 0.19
- MACD
- GPRO -0.06
- GNFT 0.03
- Stochastic Oscillator
- GPRO 37.72
- GNFT 49.75
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.